HOUSTON, Nov. 4, 2016 /PRNewswire-USNewswire/ -- Since 1941, when the Texas Legislature established the state's first cancer hospital, The University of Texas MD Anderson Cancer Center has been a beacon of hope for more than 1.1 million patients. The nation's No. 1 hospital for cancer care and research will mark its 75th anniversary with a weeklong celebration, Nov. 7-14. During its sold-out gala on Nov. 10, which has raised more than $13.5 million, Vice President Joe Biden will deliver remarks and the creation of the Beau Biden Chair for Brain Cancer Research will be announced.

Throughout its 75-year history, MD Anderson has been recognized around the globe for its contributions to the understanding, diagnosis, treatment and prevention of cancer. From early advances in diagnostic radiology and the development of mammography technology to the basic science exploration that led to immunotherapy and our ability to harness the immune system to attack cancer, MD Anderson's multi-disciplinary approach to cancer care has led to significant progress for more than seven decades. Watch this commemorative anniversary video, 75 years in 75 seconds.

"As we celebrate this historic milestone, we're inspired by the extraordinary vision of MD Anderson's forefathers, and we remain focused on our mission to end cancer by disrupting the status quo with big ideas and bold initiatives like the Moon Shots Program," said Ronald A. DePinho, M.D., president of MD Anderson. "We're honored to welcome dignitaries from around the world, including Vice President Biden and Dr. Jill Biden, to reflect on our many breakthroughs and envision Making Cancer History. As cancer fighters, we're driven by boundless hope and optimism made possible with each scientific discovery, each clinical breakthrough and each new piece of knowledge disseminated. Knowledge is cancer's greatest vulnerability and its dissemination will make a meaningful impact on patients and their families."
MD Anderson's drive and innovation have led to lifesaving advances for patients around the globe. In 2012, MD Anderson launched the Moon Shots Program™, an institution-wide effort focused on rapidly and dramatically reducing mortality and suffering in cancer. In the program's first three years of implementation, researchers and clinicians have blazed new trails in translational research, making novel cancer therapies available to patients and beginning clinical trials in first-in-class drugs.

MD Anderson also enables patients to access its care, expertise and research-based approaches through collaborations with likeminded community hospitals, health systems and academic centers. The MD Anderson Cancer Network includes 24 institutions from California to New Jersey, and the institution's international work influences the cancer care of approximately one-third of the world's population.

Rad Oncology Homepage